These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Regional brain function in schizophrenia. I. A positron emission tomography study. Gur RE; Resnick SM; Alavi A; Gur RC; Caroff S; Dann R; Silver FL; Saykin AJ; Chawluk JB; Kushner M Arch Gen Psychiatry; 1987 Feb; 44(2):119-25. PubMed ID: 3492982 [TBL] [Abstract][Full Text] [Related]
7. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Buchsbaum MS; DeLisi LE; Holcomb HH; Cappelletti J; King AC; Johnson J; Hazlett E; Dowling-Zimmerman S; Post RM; Morihisa J Arch Gen Psychiatry; 1984 Dec; 41(12):1159-66. PubMed ID: 6334502 [TBL] [Abstract][Full Text] [Related]
9. Clozapine effects on glucose metabolic rate in striatum and frontal cortex. Potkin SG; Buchsbaum MS; Jin Y; Tang C; Telford J; Friedman G; Lottenberg S; Najafi A; Gulasekaram B; Costa J J Clin Psychiatry; 1994 Sep; 55 Suppl B():63-6. PubMed ID: 7961576 [TBL] [Abstract][Full Text] [Related]
10. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Wolkin A; Jaeger J; Brodie JD; Wolf AP; Fowler J; Rotrosen J; Gomez-Mont F; Cancro R Am J Psychiatry; 1985 May; 142(5):564-71. PubMed ID: 3872603 [TBL] [Abstract][Full Text] [Related]
11. Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics. Katz M; Buchsbaum MS; Siegel BV; Wu J; Haier RJ; Bunney WE Neuropsychobiology; 1996; 33(1):1-11. PubMed ID: 8821368 [TBL] [Abstract][Full Text] [Related]
12. Brain metabolism in autism. Resting cerebral glucose utilization rates as measured with positron emission tomography. Rumsey JM; Duara R; Grady C; Rapoport JL; Margolin RA; Rapoport SI; Cutler NR Arch Gen Psychiatry; 1985 May; 42(5):448-55. PubMed ID: 3872650 [TBL] [Abstract][Full Text] [Related]
13. Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls. Siegel BV; Nuechterlein KH; Abel L; Wu JC; Buchsbaum MS Schizophr Res; 1995 Sep; 17(1):85-94. PubMed ID: 8541254 [TBL] [Abstract][Full Text] [Related]
14. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Szechtman H; Nahmias C; Garnett ES; Firnau G; Brown GM; Kaplan RD; Cleghorn JM Arch Gen Psychiatry; 1988 Jun; 45(6):523-32. PubMed ID: 2897836 [TBL] [Abstract][Full Text] [Related]
15. Cortical abnormalities in Alzheimer's disease. Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378 [TBL] [Abstract][Full Text] [Related]
16. Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography. Gur RE; Resnick SM; Gur RC; Alavi A; Caroff S; Kushner M; Reivich M Arch Gen Psychiatry; 1987 Feb; 44(2):126-9. PubMed ID: 3492983 [TBL] [Abstract][Full Text] [Related]
17. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. Buchsbaum MS; Wu J; DeLisi LE; Holcomb H; Kessler R; Johnson J; King AC; Hazlett E; Langston K; Post RM J Affect Disord; 1986; 10(2):137-52. PubMed ID: 2941470 [TBL] [Abstract][Full Text] [Related]